急重症指南

订阅

MedSci主页 / 所有栏目 / 急重症指南

2021 ICU内COVID-19重症患者管理建议

2021-12-10 国外急诊/重症相关专家小组（统称） Med Intensiva (Engl Ed)

ICUCOVID-19重症患者

COVID-19导致大量患者入住ICU，一般是由于严重呼吸衰竭。本文主要针对ICU内危重COVID-19患者的管理提供指导建议。

中文标题：

2021 ICU内COVID-19重症患者管理建议

英文标题：

Recommendations for the management of critically ill patients with COVID-19 in Intensive Care Units

发布机构：

国外急诊/重症相关专家小组（统称）

发布日期：

2021-12-10

简要介绍：

COVID-19导致大量患者入住ICU，一般是由于严重呼吸衰竭。本文主要针对ICU内危重COVID-19患者的管理提供指导建议。

相关资料下载：
[AttachmentFileName(sort=1, fileName=2021 ICU内COVID-19重症患者管理建议.pdf)] GetToolGuiderByIdResponse(projectId=1, id=907e41c002292189, title=2021 ICU内COVID-19重症患者管理建议, enTitle=Recommendations for the management of critically ill patients with COVID-19 in Intensive Care Units, guiderFrom=Med Intensiva (Engl Ed), authorId=0, author=, summary=COVID-19导致大量患者入住ICU，一般是由于严重呼吸衰竭。本文主要针对ICU内危重COVID-19患者的管理提供指导建议。, cover=https://img.medsci.cn/20211216/1639663392978_1608702.jpg, journalId=0, articlesId=null, associationId=2150, associationName=国外急诊/重症相关专家小组（统称）, associationIntro=国外急诊/重症相关专家小组（统称）, copyright=0, guiderPublishedTime=Fri Dec 10 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">COVID-19导致大量患者入住ICU，一般是由于严重呼吸衰竭。本文主要针对ICU内危重COVID-19患者的管理提供指导建议。</span></p>, tagList=[TagDto(tagId=304, tagName=ICU), TagDto(tagId=119885, tagName=COVID-19重症患者)], categoryList=[CategoryDto(categoryId=38, categoryName=急重症, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=99632, guiderKeyword=Covid-19, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=2064, appHits=67, showAppHits=0, pcHits=266, showPcHits=1997, likes=1, shares=3, comments=4, approvalStatus=1, publishedTime=Thu Dec 16 21:56:40 CST 2021, publishedTimeString=2021-12-10, pcVisible=1, appVisible=1, editorId=1608702, editor=dajiong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=dajiong, createdTime=Thu Dec 16 22:08:05 CST 2021, updatedBy=1608702, updatedName=dajiong, updatedTime=Wed Jan 03 17:51:45 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 ICU内COVID-19重症患者管理建议.pdf)])
2021 ICU内COVID-19重症患者管理建议.pdf
下载请点击：
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1081737, encodeId=34fd1081e37ca, content=厉害, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbfa5623875, createdName=ms6000000265869946, createdTime=Sun Dec 19 10:38:49 CST 2021, time=2021-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081425, encodeId=31c2108142544, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Sat Dec 18 06:54:07 CST 2021, time=2021-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081380, encodeId=8b891081380a8, content=非常棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d5c65323798, createdName=148b43aem43(暂无昵称), createdTime=Fri Dec 17 23:25:00 CST 2021, time=2021-12-17, status=1, ipAttribution=)]
    2021-12-19 ms6000000265869946

    厉害

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1081737, encodeId=34fd1081e37ca, content=厉害, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbfa5623875, createdName=ms6000000265869946, createdTime=Sun Dec 19 10:38:49 CST 2021, time=2021-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081425, encodeId=31c2108142544, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Sat Dec 18 06:54:07 CST 2021, time=2021-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081380, encodeId=8b891081380a8, content=非常棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d5c65323798, createdName=148b43aem43(暂无昵称), createdTime=Fri Dec 17 23:25:00 CST 2021, time=2021-12-17, status=1, ipAttribution=)]
    2021-12-18 微探

    学习学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1081737, encodeId=34fd1081e37ca, content=厉害, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbfa5623875, createdName=ms6000000265869946, createdTime=Sun Dec 19 10:38:49 CST 2021, time=2021-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081425, encodeId=31c2108142544, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Sat Dec 18 06:54:07 CST 2021, time=2021-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081380, encodeId=8b891081380a8, content=非常棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d5c65323798, createdName=148b43aem43(暂无昵称), createdTime=Fri Dec 17 23:25:00 CST 2021, time=2021-12-17, status=1, ipAttribution=)]
    2021-12-17 148b43aem43(暂无昵称)

    非常棒

    0

相关指南

2020 SCCM指南：ICU内成人急性和慢加急性肝衰竭的管理

美国重症医学会(SCCM,Society of Critical Care Medicine) · 2020-02-16

美国重症医学会“以家庭为中心照护循证指南”解读

暂未更新 · 2019-09-30

2018 ESPEN指南：ICU内临床营养

欧洲临床营养和代谢学会(ESPEN,The European Society for Clinical Nutrition and Metabolism) · 2018-09-29

2018 FSC意见书：ICU内心源性休克患者机械循环支持

法国心血管学会(FSC,French Society of Cardiology) · 2018-10-11

2018 SCCM临床实践指南：ICU内成人患者疼痛，躁动/镇静，谵妄，固定以及睡眠中断的管理

美国重症医学会(SCCM,Society of Critical Care Medicine) · 2018-08-20

2017 法国专家组指南：ICU内目标温度管理

国内急诊/重症相关专家小组（统称） · 2017-06-19

拓展阅读

2019冠状病毒病(COVID-19)疫情防控期间妇科急诊患者临床诊疗防护原则和措施的建议

暂未更新 · 2020-02-18

COVID-19感染患者的气管切开术共识：西班牙

西班牙重症监护医学与冠心病小组学会(SEMICYUC,Spanish Society of Intensive Care Medicine and Coronary Units) · 2020-06-01

OVID-19大流行期间妇科恶性肿瘤的放射治疗：国际专家共识建议

暂未更新 · 2020-06-23

在COVID-19大流行期间接受治疗性放疗的肺癌患者管理共识

暂未更新 · 2020-09-01

肺癌和COVID-19大流行：巴西胸部肿瘤小组的建议

巴西胸部肿瘤组织（Brazilian Thoracic Oncology Group） · 2020-09-01

COVID-19患者的化学预防，诊断，治疗和出院管理：循证临床实践指南（更新版本）

中国医院协会(CHA,Chinese Hospital Association) ·